Response

Stem Cells and Development

Volumn 13, Issue 2, 2004, Pages 162-163

  Yang, Demao ^a  

^a Yangfan Biotechnology Corporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32644464418     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/154732804323046747     Document Type: Article

References (7)

1. Chen J., W. Liu, X. Wang, H. Chen, J. Wu, Y. Yang, L. Wu, and D. Yang. (2003). Ex vivo immunotherapy for patients with benzene-induced aplastic anemia. J Hematother Stem Cell Res 12:505-514.
2. Smith M.T. (1996). Overview of benzene induced aplastic anemia. Eur J Hematol Suppl 60:107-110.
3. Gengsheng C., M. Hua, B.-L. Kong, S. Qi and B. Chen. (2002). Analysis of 13 patients with benzene induced aplastic anemia. Chinese Occupat Med. 20:34.
4. Snyder R., G. Witz, B.D. Goldstein. (1990). The toxicity of benzene. Medicinea (B Aires) 50:527-531.
5. Kojima S. (1993). Use of hematopoietic growth factors for treatment of aplastic anemia. Ann. Hematol. 66:71-75.
6. Young N.S. and N.J. Barrett. (1995). The treatment of severe acquired aplastic anemia. Blood 85:3367-3377.
7. Chen J., W. Liu, X. Wang, H. Chen, J. Wu, Y. Yang, L. Wu, and D. Yang. (2003). Ex vivo immunotherapy for patients with benzene-induced aplastic anemia. J Hematother Stem Cell Res 12:505-514.